Report Detail
Global (United States, European Union and China) Drugs for Anti-Infective Market Research Report 2019-2025
- RnM3695939 |
- 26 August, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
In 2019, the market size of Drugs for Anti-Infective is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drugs for Anti-Infective.
This report studies the global market size of Drugs for Anti-Infective, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drugs for Anti-Infective sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance
Market Segment by Product Type
OTC
Rx Drugs
Market Segment by Application
Hospital
Drugs Store
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drugs for Anti-Infective status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drugs for Anti-Infective manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drugs for Anti-Infective are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Drugs for Anti-Infective Market Size Growth Rate by Type (2019-2025)
- 1.3.2 OTC
- 1.3.3 Rx Drugs
- 1.4 Market Segment by Application
- 1.4.1 Global Drugs for Anti-Infective Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Drugs Store
- 1.4.4 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Drugs for Anti-Infective Market Size
- 2.1.1 Global Drugs for Anti-Infective Revenue 2014-2025
- 2.1.2 Global Drugs for Anti-Infective Sales 2014-2025
- 2.2 Drugs for Anti-Infective Growth Rate by Regions
- 2.2.1 Global Drugs for Anti-Infective Sales by Regions 2014-2019
- 2.2.2 Global Drugs for Anti-Infective Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Drugs for Anti-Infective Sales by Manufacturers
- 3.1.1 Drugs for Anti-Infective Sales by Manufacturers 2014-2019
- 3.1.2 Drugs for Anti-Infective Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Drugs for Anti-Infective Revenue by Manufacturers (2014-2019)
- 3.2.2 Drugs for Anti-Infective Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Drugs for Anti-Infective Market Concentration Ratio (CR5 and HHI)
- 3.3 Drugs for Anti-Infective Price by Manufacturers
- 3.4 Key Manufacturers Drugs for Anti-Infective Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Drugs for Anti-Infective Market
- 3.6 Key Manufacturers Drugs for Anti-Infective Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 OTC Sales and Revenue (2014-2019)
- 4.1.2 Rx Drugs Sales and Revenue (2014-2019)
- 4.2 Global Drugs for Anti-Infective Sales Market Share by Type
- 4.3 Global Drugs for Anti-Infective Revenue Market Share by Type
- 4.4 Drugs for Anti-Infective Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Drugs for Anti-Infective Sales by Application
6 United States
- 6.1 United States Drugs for Anti-Infective Breakdown Data by Company
- 6.2 United States Drugs for Anti-Infective Breakdown Data by Type
- 6.3 United States Drugs for Anti-Infective Breakdown Data by Application
7 European Union
- 7.1 European Union Drugs for Anti-Infective Breakdown Data by Company
- 7.2 European Union Drugs for Anti-Infective Breakdown Data by Type
- 7.3 European Union Drugs for Anti-Infective Breakdown Data by Application
8 China
- 8.1 China Drugs for Anti-Infective Breakdown Data by Company
- 8.2 China Drugs for Anti-Infective Breakdown Data by Type
- 8.3 China Drugs for Anti-Infective Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Drugs for Anti-Infective Breakdown Data by Company
- 9.2 Rest of World Drugs for Anti-Infective Breakdown Data by Type
- 9.3 Rest of World Drugs for Anti-Infective Breakdown Data by Application
- 9.4 Rest of World Drugs for Anti-Infective Breakdown Data by Countries
- 9.4.1 Rest of World Drugs for Anti-Infective Sales by Countries
- 9.4.2 Rest of World Drugs for Anti-Infective Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GlaxoSmithKline
- 10.1.1 GlaxoSmithKline Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.1.4 Drugs for Anti-Infective Product Introduction
- 10.1.5 GlaxoSmithKline Recent Development
- 10.2 Merck
- 10.2.1 Merck Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.2.4 Drugs for Anti-Infective Product Introduction
- 10.2.5 Merck Recent Development
- 10.3 Pfizer
- 10.3.1 Pfizer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.3.4 Drugs for Anti-Infective Product Introduction
- 10.3.5 Pfizer Recent Development
- 10.4 Novartis AG
- 10.4.1 Novartis AG Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.4.4 Drugs for Anti-Infective Product Introduction
- 10.4.5 Novartis AG Recent Development
- 10.5 Gilead Sciences
- 10.5.1 Gilead Sciences Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.5.4 Drugs for Anti-Infective Product Introduction
- 10.5.5 Gilead Sciences Recent Development
- 10.6 Abbott
- 10.6.1 Abbott Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.6.4 Drugs for Anti-Infective Product Introduction
- 10.6.5 Abbott Recent Development
- 10.7 Wyeth
- 10.7.1 Wyeth Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.7.4 Drugs for Anti-Infective Product Introduction
- 10.7.5 Wyeth Recent Development
- 10.8 Sanofi-Aventis
- 10.8.1 Sanofi-Aventis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.8.4 Drugs for Anti-Infective Product Introduction
- 10.8.5 Sanofi-Aventis Recent Development
- 10.9 Bristol-Myers Squibb
- 10.9.1 Bristol-Myers Squibb Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.9.4 Drugs for Anti-Infective Product Introduction
- 10.9.5 Bristol-Myers Squibb Recent Development
- 10.10 Johnson
- 10.10.1 Johnson Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Drugs for Anti-Infective
- 10.10.4 Drugs for Anti-Infective Product Introduction
- 10.10.5 Johnson Recent Development
- 10.11 Roche Pharma AG
- 10.12 Nanosphere
- 10.13 NanoViricides
- 10.14 Novabay Pharmaceuticals
- 10.15 Obetech
- 10.16 Optimer Pharmaceuticals
- 10.17 Basilea Pharmaceutica AG
- 10.18 Daiichi Sankyo
- 10.19 MerLion Pharma
- 10.20 Theravance
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Drugs for Anti-Infective Sales Channels
- 11.2.2 Drugs for Anti-Infective Distributors
- 11.3 Drugs for Anti-Infective Customers
12 Market Forecast
- 12.1 Global Drugs for Anti-Infective Sales and Revenue Forecast 2019-2025
- 12.2 Global Drugs for Anti-Infective Sales Forecast by Type
- 12.3 Global Drugs for Anti-Infective Sales Forecast by Application
- 12.4 Drugs for Anti-Infective Forecast by Regions
- 12.4.1 Global Drugs for Anti-Infective Sales Forecast by Regions 2019-2025
- 12.4.2 Global Drugs for Anti-Infective Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Drugs for Anti-Infective. Industry analysis & Market Report on Drugs for Anti-Infective is a syndicated market report, published as Global (United States, European Union and China) Drugs for Anti-Infective Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Drugs for Anti-Infective market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
